How severe is CVE-2017-17678?

CVE-2017-17678 has a CVSS 3.x base score of 6.1, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.

Is CVE-2017-17678 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (54th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2017-17678?

CVE-2017-17678 affects Bmc Remedy Mid-tier. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2017-17678?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2017-17678 published?

CVE-2017-17678 was published on 2021-05-19 and last updated on 2026-07-05.

CVE-2017-17678

CVE-2017-17678 is a medium-severity vulnerability in Bmc Remedy Mid-tier with a CVSS 3.x base score of 6.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Severity: Medium (CVSS 3.x base score 6.1)
CVSS v2: 4.3
EPSS exploit prediction: 1% (54th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-79
Affected product: Bmc Remedy Mid-tier
Published: 2021-05-19
Last modified: 2026-07-05

Description

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

Frequently asked questions

What is CVE-2017-17678?: BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
How severe is CVE-2017-17678?: CVE-2017-17678 has a CVSS 3.x base score of 6.1, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2017-17678 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (54th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2017-17678?: CVE-2017-17678 affects Bmc Remedy Mid-tier. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2017-17678?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2017-17678 published?: CVE-2017-17678 was published on 2021-05-19 and last updated on 2026-07-05.

References

Affected products (1)

cpe:2.3:a:bmc:remedy_mid-tier:9.1:sp3:*:*:*:*:*:*

More vulnerabilities in Bmc Remedy Mid-tier

CVE-2024-34399 — Critical (CVSS 9.8): **UNSUPPORTED WHEN ASSIGNED** An issue was discovered in BMC Remedy Mid Tier 7.6.04. An unauthenticated remote attacker…
CVE-2017-17674 — Critical (CVSS 9.8): BMC Remedy Mid Tier 9.1SP3 is affected by remote and local file inclusion. Due to the lack of restrictions on what can…
CVE-2017-17677 — High (CVSS 8.8): BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create…
CVE-2018-18862 — High (CVSS 8.8): BMC Remedy Mid-Tier 7.1.00 and 9.1.02.003 for BMC Remedy AR System has Incorrect Access Control in ITAM forms, as…
CVE-2017-17675 — Medium (CVSS 5.3): BMC Remedy Mid Tier 9.1SP3 is affected by log hijacking. Remote logging can be accessed by unauthenticated users,…
CVE-2024-34398 — Medium (CVSS 4.2): An issue was discovered in BMC Remedy Mid Tier 7.6.04. The web application allows stored HTML Injection by…

All CVEs affecting Bmc Remedy Mid-tier →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →